(Allergan plc)

	AGN latest price $197.3571 (-3.5%) ($197.2986 - $203.0442) on Thu. Sep. 21, 2017.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.18% (three month average)
RSI	24
Latest Price	$197.3571(-3.5%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -1.9% a day on average for past five trading days.
Weekly Trend	AGN declines -3% a week on average for past two weeks.
Market Behavior	Growth stock sell-off for large cap. Normal for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(50%)    XLV(49%)    IVE(44%)    SPY(44%)    VT(44%)
Factors Impacting AGN price	AGN will decline at least -0.59% in a week (0% probabilities).   VIXM(-29%)    TLT(-17%)    UUP(-16%)    SHY(-3%)    GDXJ(-3%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.59% (StdDev 1.18%)
Hourly BBV	0 ()
Intraday Trend	-2.7%

Resistance Level	$217.25
5 Day Moving Average	$208.3(-5.25%)
10 Day Moving Average	$215.31(-8.34%)
20 Day Moving Average	$217.25(-9.16%)
To recent high	-20.6%
To recent low	0%
Market Cap	$65.069b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed